Keyword: Becton Dickinson

Medical device maker Becton Dickinson is suing rival Cytek Biosciences and a group of former employees, claiming they stole trade secrets.

Inspectors identify violations at the Becton Dickinson site in New Jersey but allow tubes at the center of the investigation to stay on the market.

C.R. Bard scored FDA approval for its Lutonix drug-coated balloon to treat a complication of end-stage renal disease.

The U.S. trade watchdog has demanded more information from BD and C.R. Bard about their planned $24 billion merger.

BD has struck a $24 billion deal to buy C.R. Bard to strengthen its position in the markets for catheters, pumps and other items.

The FDA cleared Becton Dickinson’s catheter system for treatment of non-malignant, recurrent pleural effusion, or the collection of fluid next to the lungs.

Becton Dickinson launched a new syringe specifically for use with Eli Lilly’s concentrated insulin, which is prescribed for diabetics who need to inject higher doses of insulin daily. Previously, patients and physicians had to make do with traditional insulin syringes, which could lead to dosing errors.